NasdaqCM - Delayed Quote USD
Bright Minds Biosciences Inc. (DRUG)
32.49
+0.43
+(1.34%)
At close: May 9 at 4:00:01 PM EDT
33.20
+0.71
+(2.19%)
After hours: May 9 at 7:37:50 PM EDT
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Operating Cash Flow
-2,522.49
-1,850.19
-7,024.27
-13,587.12
-7,319.30
Financing Cash Flow
51,973.43
810.57
2,189.69
5,196.19
26,055.60
End Cash Position
56,212.59
5,720.09
6,747.99
11,627.91
19,760.02
Issuance of Capital Stock
48,628.96
900
1,217.50
4,034.88
27,744.83
Repayment of Debt
-91.56
-89.73
-86.11
-7.16
0
Free Cash Flow
-2,522.49
-1,850.19
-7,024.27
-13,587.12
-7,319.30
9/30/2021 - 3/22/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MNPR Monopar Therapeutics Inc.
39.42
-6.96%
TVGN Tevogen Bio Holdings Inc.
1.0900
0.00%
DWTX Dogwood Therapeutics, Inc.
4.5600
0.00%
BIVI BioVie Inc.
1.1200
-8.94%
CADL Candel Therapeutics, Inc.
4.8100
+1.05%
GLMD Galmed Pharmaceuticals Ltd.
1.2400
-0.80%
TOVX Theriva Biologics, Inc.
0.5299
-17.61%
PLRZ Polyrizon Ltd.
0.3747
-36.58%
TPST Tempest Therapeutics, Inc.
6.49
-5.26%
TNXP Tonix Pharmaceuticals Holding Corp.
18.83
-0.58%